Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,609.78
(
0.13%
)
US TECH 100
29,808.40
(
0.33%
)
Dow Jones
51,307.79
(
0.45%
)
Brent Oil
96.13
(
0.91%
)
Bitcoin
65,880.92
(
-1.21%
)
News Focus
News Focus

Replies to post #4790 on Gilead Sciences Inc (GILD)

Replies to #4790 on Gilead Sciences Inc (GILD)
icon url

DewDiligence

04/28/21 3:50 PM

#4791 RE: Stowe #4790

The tested cocktails still require (intravenous) remdesivir to stop SARS-CoV-2 replication. What's badly needed is an all-oral regimen.